Arcutis Biotherapeutics Inc. (ARQT): Price and Financial Metrics
ARQT Price/Volume Stats
| Current price | $10.18 | 52-week high | $13.17 |
| Prev. close | $10.09 | 52-week low | $1.76 |
| Day low | $9.93 | Volume | 1,025,300 |
| Day high | $10.42 | Avg. volume | 3,223,132 |
| 50-day MA | $9.57 | Dividend yield | N/A |
| 200-day MA | $9.47 | Market Cap | 1.19B |
ARQT Stock Price Chart Interactive Chart >
Arcutis Biotherapeutics Inc. (ARQT) Company Bio
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
ARQT Price Returns
| 1-mo | 22.06% |
| 3-mo | 3.56% |
| 6-mo | 11.14% |
| 1-year | 441.49% |
| 3-year | -39.98% |
| 5-year | N/A |
| YTD | 215.17% |
| 2023 | -78.18% |
| 2022 | -28.64% |
| 2021 | -26.27% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...